Royalty Obligation and Deferred License Fees (Details) (USD $)	3 Months Ended
	Mar. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful life	10 years
Amortization of deferred license fees [Abstract]
2013	$ 82,125
2014	109,500
2015	109,500
2016	109,500
2017	109,500
Thereafter	101,333
Total	621,458
WARF [Member]
Finite-Lived Intangible Assets [Line Items]
Amended license agreement amount	295,000
Annual license maintenance fee	25,000
WARF [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Royalty rate on sale of products and services (in hundredths)	2.00%
WARF [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Royalty rate on sale of products and services (in hundredths)	4.00%
Advanced Cell Technology, Inc. [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful life	20 years
Royalty rate on sale of products and services (in hundredths)	8.00%
Licensing fees paid	250,000
Maximum royalty payments	1,000,000
Advanced Cell Technology Inc., with Kirin Sublicense I [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful life	20 years
Royalty rate on sale of products and services (in hundredths)	5.00%
Licensing fees paid	200,000
Maximum royalty payments	600,000
Fees for sublicense (in hundredths)	20.00%
Advanced Cell Technology Inc., with Kirin Sublicense II [Member]
Finite-Lived Intangible Assets [Line Items]
Royalty rate on sale of products and services (in hundredths)	3.50%
Licensing fees paid	50,000
Fees for sublicense (in hundredths)	20.00%
Annual minimum royalty due	50,000
Reproductive Genetics Institute [Member]
Finite-Lived Intangible Assets [Line Items]
Common shares issued (in shares)	32,259
Common shares issued, market value	50,000
Lifeline Cell Technology, LLC [Member]
Finite-Lived Intangible Assets [Line Items]
Licensing fees paid	$ 250,000